Kinarus is privately funded by a broad base of investors that include current and former Senior Executives from the Life Sciences, Biotech and Pharma industries. Kinarus has been able to effectively leverage this deep expertise to effectively drive its clinical programs and business strategy.
If you are interested in more information and you are a professional or institutional investors in the sense of the FinSA please click the checkbox below:
Kinarus signed on 16 August 2021 an unbinding Memorandum of Understanding with Perfect Holding SA (Perfect) regarding the acquisition of the shares in Kinarus by Perfect by way of the issuance to the shareholders of Kinarus of new shares of Perfect against contribution in kind of the shares of Kinarus, as announced at the time. While Kinarus and Perfect are working on the implementation of such transaction, it is still possible to invest in the currently ongoing Series B financing round. The minimum investment is CHF 50 000 and such investment is only available to investors that are professional or institutional investors in the sense of the Swiss Financial Services Act (FinSA). * If you have such status and you are interested in a possible investment in Kinarus please send an email to Dr Alexander Bausch (This email address is being protected from spambots. You need JavaScript enabled to view it.).
*The information shown herein is for information purposes only and does not, and is not intended to, constitute a prospectus in the sense of the FinSA or contain an offer or invitation to invest in Kinarus in any jurisdiction where such offer or investment is not permitted. No prospectus in the sense of the FinSA will be prepared for or in connection with the offering of the share in Kinarus in the ongoing Series B financing round on the basis that Kinarus is exempt from such obligation because the shares are not offered to any investors other than professional or institutional investors in the sense of the FinSA and the shares in Kinarus will not be admitted to trading on any trading venue (exchange or multilateral trading facility) in Switzerland.
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.